Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), has rapidly spread since its first declaration by the World Health …

Background The lack of definitive treatment or preventative options for COVID‐19 led many
clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic …

Abstract Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus has
become a Public Health Emergency of International Concern. Among the various treatment …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged …

Background Convalescent plasma has been used for a long time for the treatment of various
infectious diseases. The principle is to collect antibody-containing plasma from recovered …

Background and objectives Use of convalescent plasma for coronavirus disease 2019
(COVID‐19) treatment has gained interest worldwide. However, there is lack of evidence on …

Most high-income countries are aggressively engaged in the collection and research
evaluation of convalescent plasma as a specific passive immunotherapy for treatment of …

• There is some evidence for favourable outcomes in patients who have received COVID-19
convalescent plasma, but it is not definitive. WHO recognizes COVID-19 convalescent …

The pandemic caused by the novel coronavirus, called SARS-CoV-2, affected more than
one million people around the world. The COVID-19, the acronym derived from the …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) resulted in a global pandemic in early 2020. Various …